Expression of TMBIM6 in Cancers: The Involvement of Sp1 and PKC.

Junjappa, Raghu Patil; Kim, Hyun-Kyoung; Park, Seong Yeol; Bhattarai, Kashi Raj; Kim, Kyung-Woon; Soh, Jae-Won; Kim, Hyung-Ryong; Chae, Han-Jung

Junjappa, Raghu Patil; Kim, Hyun-Kyoung; Park, Seong Yeol; Bhattarai, Kashi Raj; Kim, Kyung-Woon; Soh, Jae-Won; Kim, Hyung-Ryong; Chae, Han-Jung.

Afiliação

Junjappa RP; Department of Pharmacology and New Drug Development Research Institute, Chonbuk National University Medical School, Jeonju 54896, Korea.
Kim HK; Department of Pharmacology and New Drug Development Research Institute, Chonbuk National University Medical School, Jeonju 54896, Korea.
Park SY; Department of Pharmacology and New Drug Development Research Institute, Chonbuk National University Medical School, Jeonju 54896, Korea.
Bhattarai KR; Department of Pharmacology and New Drug Development Research Institute, Chonbuk National University Medical School, Jeonju 54896, Korea.
Kim KW; Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration (RDA), Wanju-gun, Chonbuk 54875, Korea.
Soh JW; Department of Chemistry, Inha University, Incheon 402-751, Korea.
Kim HR; College of Dentistry, Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116, Korea. hrkimdp@gmail.com.
Chae HJ; Department of Pharmacology and New Drug Development Research Institute, Chonbuk National University Medical School, Jeonju 54896, Korea. hjchae@jbnu.ac.kr.

Cancers (Basel) ; 11(7)2019 Jul 11.

Article em En | MEDLINE | ID: mdl-31336725

Palavras-chave

PKC; Sp1; TMBIM6; cancer; promoter; transcriptional regulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google